Group 1 - The presentation is led by Veronica Skevik, Vice President of Finance, alongside CFO Per Bjarne Lyngstad, from the biorefinery in Norway [1] - The agenda includes an outlook from the latest quarterly report, discussion on disruption at the Sarpsborg site, currency and commodities input, followed by a Q&A session [2] - Participants are encouraged to submit questions during the presentation [2]

Core Insights - Borregaard has faced an unexpected outage at its Sarpsborg facility, affecting the production of a key chemical for speciality cellulose, leading to shipment delays for certain grades [1] - The company has engaged with experts to address the issue and mitigate customer impact, with expected deliveries of speciality cellulose in Q3 now projected at approximately 30,000 tonnes, down from the previously forecasted 35,000 to 38,000 tonnes [2] - The estimated negative impact on the Group's EBITDA for Q3 is projected to be between NOK 40 million and NOK 50 million [2] Production Impact - The outage has restricted cellulose production to grades outside standard specifications, causing delays in shipments [1] - Other product lines at the biorefinery, including lignin-based biopolymers, bio-vanillin, bioethanol, and cellulose fibrils, have not been affected by the outage [1] Financial Implications - The revised forecast for speciality cellulose deliveries indicates a significant reduction in expected output for Q3 [2] - The financial impact of the outage is quantified, with a projected EBITDA reduction of NOK 40–50 million for the quarter [2]

Group 1: Leadership Changes - Tom Erik Foss-Jacobsen has assumed the position of CEO of Borregaard as of August 1, 2025, succeeding the previous leadership [1] - Knut-Harald Bakke has been appointed Executive Vice President of the BioSolutions business area, previously serving as Director of Investor Relations [3] - Kari Strande has been appointed Senior Vice President of Human Resources, responsible for people and organizational development, having previously led the HR Department [3] Group 2: Executive Management Continuity - Dag Arthur Aasbø will continue as Senior Vice President of Public Affairs and Sustainability, taking on overall responsibility for sustainability [4] - Ole Gunnar Jakobsen remains as Executive Vice President of Manufacturing and Technology, overseeing global manufacturing and technology across Borregaard's production units [5] Group 3: Company Strategy and Positioning - Borregaard is strategically positioned with six production units, three R&D centers, and thirteen sales offices in key markets across Europe, the Americas, and Asia, focusing on specialization and value growth [2]

Financial Performance - Operating revenues increased to NOK 2,045 million in Q2 2025, up from NOK 1,949 million in the same period last year [1] - EBITDA reached NOK 522 million, compared to NOK 510 million in the previous year [1] - Profit before tax was NOK 326 million, slightly up from NOK 322 million [2] - Earnings per share increased to NOK 2.56 from NOK 2.45 [2] Segment Performance - BioSolutions saw improved results driven by continued growth in sales to agriculture [2][3] - BioMaterials experienced an increase in results due to higher sales prices, improved product mix, and increased sales volume, although this was partly offset by higher wood costs [2] - Fine Chemicals reported a weaker result primarily due to lower sales prices for bioethanol [2] Market Conditions - Positive net currency effects were noted across all areas [2] - The company’s President and CEO highlighted strong sales to agriculture and price increases for specialty cellulose as key drivers for improved results in BioSolutions and BioMaterials [3]

Group 1 - Borregaard ASA will report its second quarter 2025 results on July 16, 2025, at 07:00 CEST [1] - A live presentation of the Q2 2025 results will take place at 08:30 CEST, available via web-TV [2] - The presentation will be conducted in English, and participants will have the opportunity to ask questions online [2] Group 2 - Relevant materials, including a press release, quarterly report, and presentation, will be accessible on Borregaard's investor website [1] - For further inquiries, Lotte Kvinlaug is the Investor Relations Officer, reachable at +47 922 86 909 [3]

Group 1 - Knut-Harald Bakke has been appointed as EVP BioSolutions, effective from 1 August 2025, succeeding Tom Erik Foss-Jacobsen, who will become CEO on the same date [1] - Bakke currently serves as Director of Investor Relations and has held the position of Energy Director at Borregaard, with prior experience at Norsk Hydro [2] - Borregaard will initiate the process to appoint a new Director of Investor Relations, with CFO Per Bjarne Lyngstad taking on the interim responsibility from 1 August [3]

Group 1: Leadership Transition - Tom Erik Foss-Jacobsen has been appointed as the new CEO of Borregaard ASA, effective from August 1, 2025, succeeding Per A. Sørlie who will retire after 26 years in the role [1][5] - Helge Aasen, chair of Borregaard's Board of Directors, expressed confidence in Foss-Jacobsen's leadership capabilities, highlighting his in-depth understanding of the business and strong results in previous roles [2][5] - Per A. Sørlie has been with Borregaard for 35 years, contributing significantly to the company's transformation into a bio-based specialty chemicals firm and driving profit growth since its listing on the Oslo Stock Exchange in 2012 [6] Group 2: Background of Tom Erik Foss-Jacobsen - Foss-Jacobsen is currently the Executive Vice President and head of BioSolutions, a position he has held since 2019, and has over 25 years of experience at Borregaard, including 21 years in leadership roles [3] - He holds a master's degree in international marketing and strategy and a bachelor's degree in civil engineering, indicating a strong educational background relevant to his new role [3] Group 3: Future Outlook - Foss-Jacobsen expressed a commitment to driving sustainable growth and creating value for Borregaard and its stakeholders, indicating a focus on the company's strategic objectives [5] - The Board will grant Foss-Jacobsen stock options upon his accession, aligning his interests with the long-term performance of the company [7]

Core Insights - Borregaard reported an increase in operating revenues to NOK 2,036 million in Q1 2025, up from NOK 1,975 million in the same quarter last year [1] - EBITDA rose to NOK 511 million, compared to NOK 442 million in the previous year [1] - Profit before tax increased to NOK 319 million from NOK 261 million year-over-year [2] BioSolutions Performance - BioSolutions achieved an all-time high result, driven primarily by strong sales to the agriculture sector [2][3] - The specialization strategy of the company has shown resilience in challenging macroeconomic conditions, which is expected to be a key driver for future success [3] BioMaterials and Fine Chemicals Performance - For BioMaterials, higher sales prices were countered by lower sales volumes and increased costs, including wood costs [2] - Fine Chemicals experienced a weaker result primarily due to lower sales prices for bioethanol [2] Earnings Per Share - Earnings per share increased to NOK 2.52, up from NOK 2.01 in the corresponding quarter last year [2]

Group 1 - Borregaard ASA will report its first quarter 2025 results on April 30, 2025, at 07:00 CEST, with a stock exchange announcement to follow [1] - A presentation of the results will take place at 08:30 CEST at SEB in Oslo, with options for in-person attendance and live web-TV streaming [2] - The presentation will be conducted in English, and participants will have the opportunity to ask questions via the web [2]

Group 1 - Borregaard ASA shares will be traded ex-dividend of NOK 4.25 per share starting from 11 April 2025 [1] - The announcement was made from Sarpsborg on 11 April 2025 [1] - The information complies with the disclosure requirements of the Norwegian Securities Trading Act [1]